- Home
- PCRX vs ARCT Comparison
PCRX vs ARCT Comparison
Compare PCRX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- ARCT
- Stock Information
- Founded
- PCRX 2006
- ARCT 2013
- Country
- PCRX United States
- ARCT United States
- Employees
- PCRX N/A
- ARCT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- PCRX Health Care
- ARCT Health Care
- Exchange
- PCRX Nasdaq
- ARCT Nasdaq
- Market Cap
- PCRX 604.7M
- ARCT 487.0M
- IPO Year
- PCRX 2011
- ARCT N/A
- Fundamental
- Price
- PCRX $23.33
- ARCT $17.42
- Analyst Decision
- PCRX Buy
- ARCT Strong Buy
- Analyst Count
- PCRX 10
- ARCT 7
- Target Price
- PCRX $27.60
- ARCT $65.00
- AVG Volume (30 Days)
- PCRX 644.2K
- ARCT 346.7K
- Earning Date
- PCRX 02-27-2025
- ARCT 03-06-2025
- Dividend Yield
- PCRX N/A
- ARCT N/A
- EPS Growth
- PCRX N/A
- ARCT N/A
- EPS
- PCRX N/A
- ARCT N/A
- Revenue
- PCRX $694,957,000.00
- ARCT $160,399,000.00
- Revenue This Year
- PCRX $4.83
- ARCT $7.33
- Revenue Next Year
- PCRX $2.16
- ARCT $4.71
- P/E Ratio
- PCRX N/A
- ARCT N/A
- Revenue Growth
- PCRX 4.40
- ARCT N/A
- 52 Week Low
- PCRX $11.16
- ARCT $14.30
- 52 Week High
- PCRX $34.01
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- PCRX 72.60
- ARCT 50.59
- Support Level
- PCRX $18.18
- ARCT $16.07
- Resistance Level
- PCRX $22.36
- ARCT $17.93
- Average True Range (ATR)
- PCRX 1.22
- ARCT 1.52
- MACD
- PCRX 0.32
- ARCT -0.06
- Stochastic Oscillator
- PCRX 96.63
- ARCT 29.41
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.